เชิงอรรถและอ้างอิง ของ วัคซีนดีเอ็นเอ

  1. 1 2 Ramos, Henrique Roman; Ho, Paulo Lee. "Developing Snake Antivenom Sera by Genetic Immunization: A Review". Clinical Toxinology in Asia Pacific and Africa. 2: 401–414.CS1 maint: uses authors parameter (link)
  2. 1 2 Liu, Shuying; Wang, Shixia; Lu, Shan (2016-04-27). "DNA immunization as a technology platform for monoclonal antibody induction". Emerging Microbes & Infections. 5 (4): e33. doi:10.1038/emi.2016.27. PMC 4855071. PMID 27048742.
  3. 1 2 3 "DNA vaccines". World Health Organization.
  4. 1 2 Khan, Kishwar Hayat (2013-03-01). "DNA vaccines: roles against diseases". Germs. 3 (1): 26–35. doi:10.11599/germs.2013.1034. PMC 3882840. PMID 24432284. ability to induce a wider range of types of immune response
  5. 1 2 "India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters (ภาษาอังกฤษ). 2021-08-20. สืบค้นเมื่อ 2021-08-22.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 13 Alarcon, JB; Waine, GW; McManus, DP (1999). "DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents". Advances in Parasitology Volume 42. Advances in Parasitology. 42. pp. 343–410. doi:10.1016/S0065-308X(08)60152-9. ISBN 9780120317424. PMID 10050276.
  7. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Robinson, HL; Pertmer, TM (2000). DNA vaccines for viral infections: basic studies and applications. Advances in Virus Research. 55. pp. 1–74. doi:10.1016/S0065-3527(00)55001-5. ISBN 9780120398553. PMID 11050940.
  8. ↑ White, LO; Gibb, E; Newham, HC; Richardson, MD; Warren, RC (July 1979). "Comparison of the growth of virulent and attenuated strains of Candida albicans in the kidneys of normal and cortison-treated mice by chitin assay". Mycopathologia. 67 (3): 173–7. doi:10.1007/bf00470753. PMID 384256. S2CID 31914107.
  9. ↑ Paoletti, E; Lipinskas, BR; Samsonoff, C; Mercer, S; Panicali, D (January 1984). "Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 81 (1): 193–7. Bibcode:1984PNAS...81..193P. doi:10.1073/pnas.81.1.193. PMC 344637. PMID 6320164.
  10. ↑ US Patent 4722848 - Method for immunizing animals with synthetically modified vaccinia virus
  11. ↑ Ulmer, J. B.; Donnelly, J. J.; Parker, S. E.; Rhodes, G. H.; Felgner, P. L.; Dwarki, V. J.; Gromkowski, S. H.; Deck, R. R.; DeWitt, C. M.; Friedman, A.; Et, Al (1993-03-19). "Heterologous protection against influenza by injection of DNA encoding a viral protein". Science (ภาษาอังกฤษ). 259 (5102): 1745–1749. Bibcode:1993Sci...259.1745U. doi:10.1126/science.8456302. ISSN 0036-8075. PMID 8456302.
  12. ↑ Regalado, Antonio (2016-08-02). "The U.S. government has begun testing its first Zika vaccine in humans". MIT Technology Review Magazine. สืบค้นเมื่อ 2016-08-06.
  13. ↑ Chen, Y; Wang, S; Lu, S (February 2014). "DNA Immunization for HIV Vaccine Development". Vaccines. 2 (1): 138–59. doi:10.3390/vaccines2010138. PMC 4494200. PMID 26344472.
  14. ↑ Ledgerwood, JE; Pierson, TC; Hubka, SA; Desai, N; Rucker, S; Gordon, IJ; Enama, ME; Nelson, S; Nason, M; Gu, W; Bundrant, N; Koup, RA; Bailer, RT; Mascola, JR; Nabel, GJ; Graham, BS (May 2011). "A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial". J Infect Dis. 203 (10): 1396–404. doi:10.1093/infdis/jir054. PMC 3080891. PMID 21398392.
  15. 1 2 Sedegah, M; Hedstrom, R; Hobart, P; Hoffman, SL (October 1994). "Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein". Proceedings of the National Academy of Sciences of the United States of America. 91 (21): 9866–70. Bibcode:1994PNAS...91.9866S. doi:10.1073/pnas.91.21.9866. JSTOR 2365723. PMC 44918. PMID 7937907.
  16. ↑ Harmon, B. T.; Aly, A. E.; Padegimas, L.; Sesenoglu-Laird, O.; Cooper, M. J.; Waszczak, B. L. (2014). "Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain". Gene Therapy. 21 (5): 514–521. doi:10.1038/gt.2014.28. PMID 24670994. S2CID 5560134.
  17. ↑ Mor, G; Klinman, DM; Shapiro, S; Hagiwara, E; Sedegah, M; Norman, JA; Hoffman, SL; Steinberg, AD (August 1995). "Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA". Journal of Immunology. 155 (4): 2039–46. PMID 7636255.
  18. ↑ Leitner, WW; Seguin, MC; Ballou, WR; Seitz, JP; Schultz, AM; Sheehy, MJ; Lyon, JA (December 1997). "Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites". Journal of Immunology. 159 (12): 6112–9. PMID 9550412.
  19. ↑ Böhm, W; Kuhröber, A; Paier, T; Mertens, T; Reimann, J; Schirmbeck, R (June 1996). "DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection". Journal of Immunological Methods. 193 (1): 29–40. doi:10.1016/0022-1759(96)00035-X. PMID 8690928.
  20. 1 2 3 4 5 6 7 8 9 Lewis, PJ; Babiuk, LA (1999). DNA vaccines: a review. Advances in Virus Research. 54. Academic Press. pp. 129–88. doi:10.1016/S0065-3527(08)60367-X. ISBN 978-0-12-039854-6. PMID 10547676.
  21. ↑ André, S; Seed, B; Eberle, J; Schraut, W; Bültmann, A; Haas, J (February 1998). "Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage". Journal of Virology. 72 (2): 1497–503. doi:10.1128/JVI.72.2.1497-1503.1998. PMC 124631. PMID 9445053.
  22. ↑ Muthumani, K; Zhang, D; Dayes, NS; Hwang, DS; Calarota, SA; Choo, AY; Boyer, JD; Weiner, DB (September 2003). "Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo". Virology. 314 (1): 134–46. doi:10.1016/S0042-6822(03)00459-8. PMID 14517067.
  23. ↑ Oliveira, PH; Prather, KJ; Prazeres, DM; Monteiro, GA (September 2009). "Structural instability of plasmid biopharmaceuticals: challenges and implications". Trends in Biotechnology. 27 (9): 503–11. doi:10.1016/j.tibtech.2009.06.004. PMID 19656584.
  24. ↑ Oliveira, PH; Mairhofer, J (September 2013). "Marker-free plasmids for biotechnological applications - implications and perspectives". Trends in Biotechnology. 31 (9): 539–47. doi:10.1016/j.tibtech.2013.06.001. PMID 23830144.
  25. ↑ Kutzler, MA; Weiner, DB (October 2008). "DNA vaccines: ready for prime time?". Nature Reviews. Genetics. 9 (10): 776–88. doi:10.1038/nrg2432. PMC 4317294. PMID 18781156.
  26. ↑ Rodriguez, F; Zhang, J; Whitton, JL (November 1997). "DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction". Journal of Virology. 71 (11): 8497–503. doi:10.1128/JVI.71.11.8497-8503.1997. PMC 192313. PMID 9343207.
  27. 1 2 Tobery, TW; Siliciano, RF (March 1997). "Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization". The Journal of Experimental Medicine. 185 (5): 909–20. doi:10.1084/jem.185.5.909. PMC 2196169. PMID 9120397.
  28. ↑ Huebener, N; Fest, S; Strandsby, A; Michalsky, E; Preissner, R; Zeng, Y; Gaedicke, G; Lode, HN (July 2008). "A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity". Molecular Cancer Therapeutics. 7 (7): 2241–51. doi:10.1158/1535-7163.MCT-08-0109. PMID 18645033.
  29. ↑ Wunderlich, G; Moura, IC; del Portillo, HA (October 2000). "Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection". Infection and Immunity. 68 (10): 5839–45. doi:10.1128/IAI.68.10.5839-5845.2000. PMC 101545. PMID 10992493.
  30. ↑ Weiner, DB; Kennedy, RC (1999). "Genetic vaccines". Scientific American. 281 (1): 34–41. Bibcode:1999SciAm.281a..50W. doi:10.1038/scientificamerican0799-50. PMID 10396782. คลังข้อมูลเก่า เก็บจาก แหล่งเดิม เมื่อ 2009-03-25. สืบค้นเมื่อ 2007-11-21.
  31. ↑ Widera, G; Austin, M; Rabussay, D; Goldbeck, C; Barnett, SW; Chen, M; Leung, L; Otten, GR; Thudium, K; Selby, MJ; Ulmer, JB (May 2000). "Increased DNA vaccine delivery and immunogenicity by electroporation in vivo". Journal of Immunology. 164 (9): 4635–40. doi:10.4049/jimmunol.164.9.4635. PMID 10779767.
  32. ↑ Daheshia, M; Kuklin, N; Kanangat, S; Manickan, E; Rouse, BT (August 1997). "Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10". Journal of Immunology. 159 (4): 1945–52. PMID 9257860.
  33. ↑ Chen, Y; Webster, RG; Woodland, DL (March 1998). "Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination". Journal of Immunology. 160 (5): 2425–32. PMID 9498786.
  34. ↑ Lode, HN; Huebener, N; Zeng, Y; Fest, S; Weixler, S; Gaedicke, G (December 2004). "DNA minigene vaccination for adjuvant neuroblastoma therapy". Annals of the New York Academy of Sciences. 1028 (1): 113–21. Bibcode:2004NYASA1028..113L. doi:10.1196/annals.1322.012. PMID 15650237. S2CID 27240738.
  35. ↑ Sizemore, DR; Branstrom, AA; Sadoff, JC (October 1995). "Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization". Science. 270 (5234): 299–302. Bibcode:1995Sci...270..299S. doi:10.1126/science.270.5234.299. PMID 7569980. S2CID 12532901.
  36. ↑ Barry, MA; Lai, WC; Johnston, SA (October 1995). "Protection against mycoplasma infection using expression-library immunization". Nature. 377 (6550): 632–5. Bibcode:1995Natur.377..632B. doi:10.1038/377632a0. PMID 7566175. S2CID 4306972.
  37. ↑ Fynan, EF; Webster, RG; Fuller, DH; Haynes, JR; Santoro, JC; Robinson, HL (December 1993). "DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations". Proceedings of the National Academy of Sciences of the United States of America. 90 (24): 11478–82. Bibcode:1993PNAS...9011478F. doi:10.1073/pnas.90.24.11478. PMC 48007. PMID 8265577.
  38. 1 2 3 4 Feltquate, DM; Heaney, S; Webster, RG; Robinson, HL (March 1997). "Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization". Journal of Immunology. 158 (5): 2278–84. PMID 9036975.
  39. 1 2 3 Boyle, CM; Morin, M; Webster, RG; Robinson, HL (December 1996). "Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein". Journal of Virology. 70 (12): 9074–8. doi:10.1128/JVI.70.12.9074-9078.1996. PMC 191015. PMID 8971047.
  40. ↑ Sällberg, M; Townsend, K; Chen, M; O'Dea, J; Banks, T; Jolly, DJ; Chang, SM; Lee, WT; Milich, DR (July 1997). "Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens". Journal of Virology. 71 (7): 5295–303. doi:10.1128/JVI.71.7.5295-5303.1997. PMC 191766. PMID 9188598.
  41. ↑ Banchereau, J; Steinman, RM (March 1998). "Dendritic cells and the control of immunity". Nature. 392 (6673): 245–52. Bibcode:1998Natur.392..245B. doi:10.1038/32588. PMID 9521319. S2CID 4388748.
  42. ↑ Jakob, T; Walker, PS; Krieg, AM; Udey, MC; Vogel, JC (September 1998). "Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA". Journal of Immunology. 161 (6): 3042–9. PMID 9743369.
  43. 1 2 Raz, E; Tighe, H; Sato, Y; Corr, M; Dudler, JA; Roman, M; Swain, SL; Spiegelberg, HL; Carson, DA (May 1996). "Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization". Proceedings of the National Academy of Sciences of the United States of America. 93 (10): 5141–5. Bibcode:1996PNAS...93.5141R. doi:10.1073/pnas.93.10.5141. PMC 39421. PMID 8643542.
  44. 1 2 Fu, TM; Friedman, A; Ulmer, JB; Liu, MA; Donnelly, JJ (April 1997). "Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization". Journal of Virology. 71 (4): 2715–21. doi:10.1128/JVI.71.4.2715-2721.1997. PMC 191393. PMID 9060624.
  45. 1 2 3 Restifo, NP; Bacík, I; Irvine, KR; Yewdell, JW; McCabe, BJ; Anderson, RW; Eisenlohr, LC; Rosenberg, SA; Bennink, JR (May 1995). "Antigen processing in vivo and the elicitation of primary CTL responses". Journal of Immunology. 154 (9): 4414–22. PMC 1952186. PMID 7722298.
  46. 1 2 3 Iwasaki, A; Stiernholm, BJ; Chan, AK; Berinstein, NL; Barber, BH (May 1997). "Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines". Journal of Immunology. 158 (10): 4591–601. PMID 9144471.
  47. ↑ Weiss, WR; Ishii, KJ; Hedstrom, RC; Sedegah, M; Ichino, M; Barnhart, K; Klinman, DM; Hoffman, SL (September 1998). "A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine". Journal of Immunology. 161 (5): 2325–32. PMID 9725227.
  48. ↑ Tsuji, T; Hamajima, K; Fukushima, J; Xin, KQ; Ishii, N; Aoki, I; Ishigatsubo, Y; Tani, K; และคณะ (April 1997). "Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12". Journal of Immunology. 158 (8): 4008–13. PMID 9103472.
  49. 1 2 Justewicz, DM; Webster, RG (October 1996). "Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization". Virology. 224 (1): 10–7. doi:10.1006/viro.1996.0501. PMID 8862394.
  50. ↑ Mancini-Bourgine, M; Fontaine, H; Bréchot, C; Pol, S; Michel, ML (May 2006). "Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers". Vaccine. 24 (21): 4482–9. doi:10.1016/j.vaccine.2005.08.013. PMID 16310901.
  51. 1 2 Wolff, JA; Dowty, ME; Jiao, S; Repetto, G; Berg, RK; Ludtke, JJ; Williams, P; Slautterback, DB (December 1992). "Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle". Journal of Cell Science. 103. 103 ( Pt 4) (4): 1249–59. doi:10.1242/jcs.103.4.1249. PMID 1487500.
  52. ↑ Anderson, RG; Kamen, BA; Rothberg, KG; Lacey, SW (January 1992). "Potocytosis: sequestration and transport of small molecules by caveolae". Science. 255 (5043): 410–1. Bibcode:1992Sci...255..410A. doi:10.1126/science.1310359. PMID 1310359.
  53. 1 2 Casares, S; Inaba, K; Brumeanu, TD; Steinman, RM; Bona, CA (November 1997). "Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope". The Journal of Experimental Medicine. 186 (9): 1481–6. doi:10.1084/jem.186.9.1481. PMC 2199124. PMID 9348305.
  54. 1 2 Bennett, RM; Gabor, GT; Merritt, MM (December 1985). "DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA". The Journal of Clinical Investigation. 76 (6): 2182–90. doi:10.1172/JCI112226. PMC 424340. PMID 3001145.
  55. ↑ Bennet, RM; Hefeneider, SH; Bakke, A; Merritt, M; Smith, CA; Mourich, D; Heinrich, MC (May 1988). "The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes". Journal of Immunology. 140 (9): 2937–42. PMID 2452195.
  56. ↑ Corr, M; Lee, DJ; Carson, DA; Tighe, H (October 1996). "Gene vaccination with naked plasmid DNA: mechanism of CTL priming". The Journal of Experimental Medicine. 184 (4): 1555–60. doi:10.1084/jem.184.4.1555. PMC 2192808. PMID 8879229.
  57. ↑ Chattergoon, MA; Robinson, TM; Boyer, JD; Weiner, DB (June 1998). "Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells". Journal of Immunology. 160 (12): 5707–18. PMID 9637479.
  58. 1 2 Torres, CA; Iwasaki, A; Barber, BH; Robinson, HL (May 1997). "Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations". Journal of Immunology. 158 (10): 4529–32. PMID 9144463.
  59. ↑ Franco, A; Guidotti, LG; Hobbs, MV; Pasquetto, V; Chisari, FV (August 1997). "Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice". Journal of Immunology. 159 (4): 2001–8. PMID 9257867.
  60. ↑ Mancini, M; Hadchouel, M; Davis, HL; Whalen, RG; Tiollais, P; Michel, ML (October 1996). "DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state". Proceedings of the National Academy of Sciences of the United States of America. 93 (22): 12496–501. Bibcode:1996PNAS...9312496M. doi:10.1073/pnas.93.22.12496. PMC 38020. PMID 8901610.
  61. ↑ Doolan, DL; Hoffman, SL (July 1999). "IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model". Journal of Immunology. 163 (2): 884–92. PMID 10395683.

แหล่งข้อมูลอื่น

Scholia has a profile for วัคซีนดีเอ็นเอ (DNA vaccine).
การพัฒนา
กลุ่ม
การจัดการ
วัคซีน
แบคทีเรีย
ไวรัส
โพรโทซัว
หนอนพยาธิ
อื่น ๆ
เรื่องโต้แย้ง
บทความที่สัมพันธ์กัน

ใกล้เคียง

วัคซีนโควิด-19 ของไฟเซอร์-ไบออนเทค วัคซีนโควิด-19 วัคซีนอาร์เอ็นเอ วัคซีนโควิด-19 ของออกซฟอร์ด-แอสตร้าเซนเนก้า วัคซีนเชื้อลดฤทธิ์ วัคซีน วัคซีนโควิด-19 ของโมเดอร์นา วัคซีนโควิด-19 สปุตนิกวี วัคซีนโควิด-19 ของจอห์นสันแอนด์จอห์นสัน วัคซีนโควิด-19 BBIBP-CorV ของซิโนฟาร์ม